AndhraNews.net
Home » Features » Health » Swine Flu / A/H1N1

Swine Flu / A/H1N1


About Swine Flu

On October 3, 2009, the first doses of swine flu vaccine are made ready for use by U.S. doctors who will get them in about three week time. About 600,000 tubes of AstraZeneca Plc's nasal spray vaccine are scheduled to arrive by October 6, 2009.

In June 09, Scientists have come up with a fast and cost-effective way to detect the H1N1 swine-derived influenza A virus in human clinical samples using standard lab equipment. In August 09, the WHO annoinced the first swine flu vaccine are likely to be ready for use by September 09.

Taking care of Swine Flu

Here are a few precautions / care to be taken in regard to swine flu.

  • When sick, stay at home
  • Wash hands frequently with soap and water or use an alcohol based hand gel
  • Wash hands prior to touching eyes, nose and mouth
  • When coughing or sneezing, cover mouth and nose using tissues which should be disposed of immediately
  • Don't share items such as cigarettes, glasses or cups, lipstick, toys or anything which could be contaminated with respiratory secretions
  • Maintain at least one metre distance from people who have flu-like symptoms such as coughing or sneezing

may not be totally correct because: ""Analysis of the genome indicates it contains genetic fragments from Asian and European pigs as well as birds and humans of unknown source. Since the origin of the genetic elements came from four sources, it's called a quadruple reassortment virus.

Naming Swine Flu

John Tudor, Ph.D., a microbiologist at Saint Joseph's University, Philadelphia feels that naming 'Swine flu' may not be totally correct because "Analysis of the genome indicates it contains genetic fragments from Asian and European pigs as well as birds and humans of unknown source. Since the origin of the genetic elements came from four sources, it's called a quadruple reassortment virus".

Swine Flu vaccie / research

Global Epidemic

According to a World Health Organization report dated May 16, 2009, 8451 cases of influenza A(H1N1) infection are reported all over the world with Mexico and Canada reporting the most. The report dated May 21, 2009 has put the total cases to 11034 and deaths at 85. USA leads the charts with 5710 reported cases while Mexico reported the highest number of deaths - 75. As of May 26, 2009, the total death toll due to A/H1N1 reached 100. As of June 15, 2009, 76 countries have been officially reported 35,928 cases and 163 deaths. According to WHO Update 57 on Influenza A(H1N1) dated Sunday, July 05, 2009, there are 44287 confirmed cases and 180 deaths. According to WHO Update 51 on Influenza A(H1N1) dated June 19, 2009, there are 89921 confirmed cases and 382 deaths.

Experts who studied the death of two people in San Francisco feel that the A/H1N1 is more active than seasonal influenza and infectious disease. Another study highlighted the need for anti-viral drug distribution centres and swine flu testing clinics.

A/H1N1 in US

On May 25, 2009, a death is reported in Illinois, Chicago taking the US Swine-flu death toll to 12. 2 people in California died of A/H1N1 on June 1, 2009. On September 18, 2009, US Centers for Disease Control and Prevention (CDC) officials announced the first batch of A/H1N1 flu vaccinations will come in the form of a nasal spray.

A/H1N1 in Brazil

On May 21, 2009, the Brazilian Health Ministry said the number of confirmed cases in Brazil are 9. The latest of them was a 39-year olf man from Sao Paulo who returned from the US. The other 8 cases are treated and are already sent home. According to Brazil Ministry of Health, as of June 19, 2009, the officially reported number of cases rose to 180. São Paulo, Rio de Janeiro, Distrito Federal, Paraná, Rio Grande do Sul, Bahia and Minas Gerais are few regions with reported cases.

A/H1N1 in Mexico

Mexico reported the majority of A/H1N1 positive cases. As many as 3102 have falled ill and 68 are reported to have died due to the flu. As of July 3, 2009, there are 10262 confirmed cases and 119 deaths.

A/H1N1 in Chile

As of July 3, 2009, there are 7376 confirmed cases and 14 deaths in Chile.

A/H1N1 in UK

As per UK's Health Protection Agency numbers, there are 87 confirmed A/H1N1 cases and 172 possible cases in laboratory investigations in the UK (as per May 16, 2009 report). The number of confirmed cases in UK rose to 255 after 9 new cases are reported on June 1, 2009.

The family of UK's first UK swine flu fatality - the family of Jacqui Fleming, the mother-of-three from Glasgow who has become the first person in Europe to die of swine flu said she is devasted for what has happened. Reports by Medical professionals in June 09 reported that the virus can spread up to 50% of Britons population.

A/H1N1 in Australia

With a 17-year old boy from Melbourne's northern suburbs being tested postitive on May 20, 2009, the total number of confrimed A/H1N1 cases in Australia reached 11. On May 25, 2009, Australian Health Minister said that the number of A/H1N1 cases might increase from the existing 23. On May 26, 2009, A 41-year old man who returned to Canberra from a trip to the US is tested postive. Australia has reported 24 confirmed cases of A/H1N1 - 13 in Victoria, 4 in New South Wales, 2 in South Australia and Queensland and 1 in Western Australia and ACT. During the end of May 09, reports are out that the Australian Government has ordered for 10 million doses of H1N1 vaccine developed by pharma company CSL Ltd. A three-year-old Victorian boy became the first Swine flu victim in Australia. On July 2, 2009, two student nurses at Prince Charles Hospital, Brisbane are confirmed to be having swine flu, according to a Queensland Health spokesman. All patients who might have had contact with the nurses are reported to have been contacted and treated with antiviral medication.

A/H1N1 in New Zealand

New Zealand confirmed its 10th A/H1N1 infected patient after a child who returned from North America is tested positive. By July 1, 2009, the number of confirmed cases rose to 711.

A/H1N1 in Fiji

The Fiji Health Ministry confirmed its first influenza A/H1N1 case on June 20, 2009 when a 36-year-old male Fiji resident returned home from Australia. About 1600 passengers are tested after flu-like symptoms after a cruise ship Pacific Star was docked in Savusavu, Fiji's north.

A/H1N1 in Brunei

With 10 more new cases reported in July 7, 2009, the total number of the cases in the country rose to 174.

A/H1N1 in Asia & Middle East

H1N1 in Qatar

On June 17, 2009, Qatar reported its first confirmed A/H1N1 case in two boys. Regions such as the Middle East have are now increasingly proneto the virus.

A/H1N1 in Philippines

The Philippine Government's Health Secretary Francisco Duque confirmed the first case of flu in Philippines. The patient, a lady who returned from the US on May 18, 2009 is reportedly kept in isolation.

A/H1N1 in Turkey

A US citizen who arrived at the Istanbul International Airport, Turkey from Amsterdam to Iraq on May 14, 2009 is reported to have been tested postive.

H1N1 in China

Ministry of Health, China confirmed its third A/H1N1 infection after a 18-year-old woman who recently returned to Beijing from school in New York is tested positive.

On May 17, 2009, Wen Jiabao and Li Keqiang visited China's first diagnosed A/H1N1 flu patient surnamed Liu. They met the Beijing Ditan Hospital medical staff and inspected the Chinese Center for Disease Control and Prevention.

On September 3, 2009, Sinovac Biotech Ltd. (NYSE: SVA), a leading provider of biopharmaceutical products in China, announced today that the State Food and Drug Administration (SFDA) has approved the registration application for PANFLU.1, Sinovac's H1N1 vaccine, and has issued Sinovac a production license for this vaccine.

On September 4, 2009, the People's Republic of China has issued the initial order to Sinovac to purchase H1N1 vaccine for the national stockpiling plan. According to the initial order, Sinovac is required to complete the production of 3.3 million doses of PANFLU.1 (15ug/0.5ml), the H1N1 vaccine manufactured by Sinovac, before September 15, 2009. Two doses of the vaccine are packaged in one vial.

A/H1N1 in India

The first A/H1N1 case in India is reported in Hyderabad on May 16, 2009 when a 23-year-old man was found to be infected with Influenza AH1N1. On September 4, 09, four deaths are reported in Karnataka on Friday taking the toll to 35. On September 12, 09, the Karnataka Health Department confirmed four women deaths from swine flu in the state

A/H1N1 in Saudi Arabia

On July 27, 2009, S. Arabia confirmed its swine flu death.

A/H1N1 in Thailand

Thailand confirmed its 5th A/H1N1 flu case on Tuesday, June 02, 2009

A/H1N1 in Japan

In May 09, 9 students in Osaka, Western Japan and 12 from Kobe city are reported to have been tested positive for A/H1N1.

A/H1N1 in Hong Kong

2 cases of the flu are reported on May 25, 2009 taking the total toll of confirmed cases in Hong Kong to 9. On June 17, 2009, Singapore confirmed 17 new cases taking the total count to 66.

A/H1N1 in Vietnam

In June 09, reports are out that Vietnam has put aside US$ 8 million to fight A/H1N1.

Swine Flu and celebrities

A/H1N1 in news

PEN Inc.'s HALO Surface Cleaner Proven Effective Against MERS, H1N1 and Ebola Virus
DEERFIELD BEACH, FL--(Marketwired - September 10, 2015) - PEN Inc. (OTCQB: PENC) ("PEN" or "the Company"), a global leader in enhanced performance products enabled by nanotechnology to solve everyday problems, today announced that its environmentally friendly HALO™ product can help prevent the spread of viruses that cause Middle East Respiratory Syndrome (MERS), H1N1 (Swine Flu) and Ebola.

Animal Feed Additives Market Anticipated to Be Worth $19.54 Billion by 2020: Grand View Research, Inc.
The global animal feed additives market is expected to reach USD 19.54 billion by 2020, according to a new study by Grand View Research, Inc. Growing protein demand, especially in Asia Pacific and Latin America, is expected to be a key driver for additive demand over the next six years

Andhra Pradesh News on July 28 , 2015
Andhra Pradesh News and Headlines on July 28, 2015

'India's Cities have a Plethora of Plans but Little Vision or Value'
Business Wire IndiaMany of our Acts and regulations are antiquated; we should rewrite them. What we need are modern laws and collaborative individuals who can work with the system

Sierra Leone Pilot Study of 10 Minute Ebola Rapid Test Shows Promise
Medical diagnostic manufacturer JAJ International, Inc. (www.jajinternational.com) a subsidiary of LuSys Laboratories, Inc., receives promising results from a Sierra Leone Pilot Study for their Point of Care 10 Minute Ebola Rapid Test Diagnostic.

International Antiviral Therapeutics Report 2014-Technologies, Markets and Companies (Updated)
Research and Markets (http://www.researchandmarkets.com/research/rmhmmj/antiviral) has announced the addition of a new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.

First-of-Its-Kind Face Mask Provides Critical Layer of Protection Against the Flu
MUNDELEIN, IL--(Marketwired - January 21, 2014) - Each flu season, common practice for fighting the flu includes the flu shot and proper hand hygiene. Yet, statistics show, it's not enough

Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company today announced that Michael Yorba of Clear Channel's Business Talk Radio Show, The Traders Network, interviewed CEO Dr. Eugene Seymour live on December 19, 2013.

NanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AM
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company announced today that CEO Dr. Eugene Seymour will be interviewed live by Michal Yorba on Clear Channel Business Talk Radio's Traders Financial Network, Thursday, December 19th, 2013, at 2:00pm CST / 12:00pm PST / 3:00pm EST.

Skystar Bio-Pharmaceutical Reports First Quarter 2013 Results
Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today reported unaudited first quarter fiscal year 2013 earnings, for the fiscal period ended March 31, 2013.

Cheapflights.ca Looks Ahead to Summer
While spring has just sprung, many Canadians are already looking forward to and planning ahead for travel this summer. And, given this past winter, who can blame us? So the travel experts at Cheapflights

Cholesterol Beats Swine Flu, Avian Flu and Corona Viruses: Viroblock Launches New Face Mask
Viroblock SA, a Swiss start-up, today presented new data at ICPIC 2013 in Geneva, showing that their face-mask containing proprietary novel cholesterol depletion technology traps and kills over 99.9995% of H1N1 flu viruses (swine flu), 99.999% of H5N1 flu viruses (avian flu) and 99.997% human corona viruses on pass through air

Andhra Pradesh News on October 22, 2012
Andhra Pradesh News and Headlines on October 22, 2012

Andhra Pradesh News on May 8, 2012
Andhra Pradesh News and Headlines on May 8, 2012 - Jagati Publications, Indira Television and Janani Infra bank accounts freezed by CBI.

Vaccine Sales Hurt by Weak Flu Season Last Year: Kalorama
For the first time in a decade, sales of vaccines declined, according to Kalorama Information. The Healthcare market research publisher notes that a weak flu season last year which resulted in a decline in influenza vaccine sales, along with some other product changes, led to a 30% decline in the market to $19.8 billion in 2011, down from $24.1 billion in 2010

Q&A: How real is the threat of a global pandemic involving H5N1 or a related virus?
Andy Sheldon is the CEO of Medicago Inc. (TSX: MDG) (OTCQX: MDCGF) (PINK:MDCGF).His firm has completed a Phase I and a Phase II clinical trial of an H5 pandemic flu VLP vaccine candidate and he shares with BioMedReports an overview of progress onseveral fronts in this exclusive interview. How real is the threat of a global pandemic involving H5N1 or a related virus? Very real

Made-in-Singapore H5N1 Bird Flu Diagnostic Kit - Detects All Known Strains of H5N1 Virus with a Single Test
The close collaboration between scientists from the Experimental Therapeutics Centre (ETC) under the Agency for Science and Technology Research (A*STAR) and clinicians from Tan Tock Seng Hospital (TTSH) has enabled the successful development of the most comprehensive and rapid H5N1 bird flu test kit available to date

2009 swine flu outbreak may have been 15 times deadlier
The swine flu pandemic of 2009 killed an estimated 284,500 people, about 15 times the number that was confirmed by laboratory tests at the time, a new study has revealed.

Why swine flu virus develops drug resistance
Using computer chips of a type more commonly found in games consoles, researchers have revealed how the swine flu virus resists anti-flu drugs like Relenza and Tamiflu.

New protein may fight flu outbreak
Researchers have come up with a new protein that can combat deadly flu epidemics.

H1N1 discovery could lead to development of universal flu vaccines
Researchers at the University of British Columbia have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations.

Gene that transforms mild influenza to life-threatening disease identified
Researchers have identified for the first time a human gene that influences how we respond to influenza infection.

Deadly bird flu studies to be kept secret for now over fear of bioterrorism risks
World Health Organization (WHO) has announced that two studies showing how scientists mutated the H5N1 bird flu virus into a form that could cause a deadly human pandemic will be published only after experts fully assess the risks.

Peptides that could lead to universal vaccine for influenza identified
Scientists have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.

Mumbai woman tests positive for H1N1
A 26-year-old woman tested positive for H1N1 or swine flu on Thursday in Mumbai, and both she and her son have been admitted to hospital in Thane, a newspaper report said Friday.

Greenlime Continues To Lead The Hygiene Revolution
Pudumjee Hygiene Products Limited is a subsidiary of the Pudumjee group - India’s pioneers in specialty paper making. They have used this competence to develop and market a wide range of holistic products to suit different hygiene needs under its brand – Greenlime. Greenlime covers a variety of new age hygiene solutions and cater to different sectors

Researchers say legislation to ban burqa will test foundations of modern liberal society
According to a study by researchers from Queen Mary, University of London and the University of Sussex, legislation against, and to criminalize face-veiling which has swept across the EU recently will test the foundations of modern liberal society.

UK study warns of 'extreme' flu pandemic due to Olympics related tourist inflow
A study has warned that the presence of an additional 5.3 million tourists in Britain during the London Olympics will increase the risk of a flu pandemic.

Gene that protects you from flu identified
A key gene has been identified that helps people fight against the flu, say scientists.

Southampton researchers identify key peptides that could lead to a universal vaccine for influenza
Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.

Southampton Varsity identify key peptides that could lead to universal vaccine for influenza
Researchers at the University of Southampton, University of Oxford and Retroscreeen Virology Ltd have discovered a series of peptides, found on the internal structures of influenza viruses that could lead to the development of a universal vaccine for influenza, one that gives people immunity against all strains of the disease, including seasonal, avian, and swine flu.

14 new side effects found of widely prescribed swine flu drug Tamiflu
Thousands of people in Britain who took Tamiflu during the swine flu pandemic may have suffered a string of side-effects they were not warned about, it has been revealed.

UK schoolboy fights cancer with help from Man U heroes
A UK schoolboy has successfully battled leukaemia with the help of his Manchester United heroes.

Potential vaccine against flu viruses identified
Scientists have found a potential universal vaccine to fight against infection caused by various influenza viruses, including the highly pathogenic avian H5 virus and the pandemic H1 ("swine flu") virus.

Coming soon, 'supercomputers' that can predict the future
The European Union is all set to fund a 900 million-pound scheme to produce a computer system that could predict spread of diseases and impending financial meltdowns.

Soon, single vaccine to give lifelong protection against all flu strains
A single flu vaccine that would protect against all strains of the virus for life may be coming soon, which could make annual flu jabs that cost the NHS around 100m pound per year a history.

Promising new drug to treat 'deadliest' skin cancer developed
Researchers have developed a new drug to treat malignant melanoma, a deadliest form of skin cancer.

Coming soon: a 'needle-free' edible vaccine!
Australian scientists are one step closer towards developing a revolutionary vaccine, which could be swallowed with food rather than being injected.

Bionor Pharma's Universal Influenza Vaccine, Vacc-Flu, Targets Regions Shared by All Influenza A Strains; Reduces Serious Flu Symptoms by 25 Percent Over Standard Flu Vaccine in Animal Study
Summary of Findings Bionor's Vacc-Flu could be "Universal," meaning that it could work on seasonal flu and also on known pandemic flu strains such as Swine or Avian flu and well as new pandemic strains that may appear in the future. Researchers designed Vacc-Flu to work by targeting conserved domains, the regions of the virus common to all known influenza A

New Medline Surgical Face Mask First in U.S. to Inactivate Influenza Viruses and Seasonal and Pandemic Flu Strains
A new surgical face mask from Medline Industries, Inc., that is shown to inactivate 99.99 percent of laboratory tested flu viruses, including imminent pandemic and seasonal strains of influenza viruses, such as H1N1, Avian flu and Swine flu, has been cleared by the FDA to be marketed in the United States.

AVI BioPharma and Naval Medical Research Center Successfully Complete Simultaneous Rapid-Response Exercises Against Bacterial and Viral Threats in 18 Days
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, and the Naval Medical Research Center (NMRC) in Silver Spring, MD, today announced the successful completion of a formal rapid-response exercise conducted by the Joint Project Manager Transformational Medical Technologies (JPM-TMT) of the Defense Threat Reduction Agency (DTRA)

Biosimilar and Biomarker Approvals to Cut Costs - Research Report on Micromet, Inc. and CEL-SCI Corporation
Today, www.EquityMarketsInc.com announced its research report highlighting Micromet, Inc. (NASDAQ: MITI) and CEL-SCI Corporation (NYSE Amex: CVM). Full content and research is available at www.EquityMarketsInc.com/research.php.

Comment on this story

Share